Company Pardes Biosciences, Inc.
Equities
PRDS
US69945Q1058
Biotechnology & Medical Research
Business Summary
Number of employees: 57
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Chief Operating Officer | - | - | |
Ann D. Kwong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Patrick O’Brien
IRC | Investor Relations Contact | - | - |
Dave Kuo
HRO | Human Resources Officer | - | - |
Sean P. Brusky
PRN | Corporate Officer/Principal | 47 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,331,613 | 36,906,514 ( 58.28 %) | 1,319,857 ( 2.084 %) | 58.28 % |
Company contact information
Pardes Biosciences, Inc.
2173 Salk Avenue Suite 250
92008, Carlsbad
+
![address Pardes Biosciences, Inc.(PRDS)](https://cdn.zonebourse.com/static/address/131203376.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |